Patients
New hope for ovarian cancer, with Alexander Schneider
Alexander Schneider, CEO of CureLab Oncology, shares how his company’s drug candidate for platinum-resistant ovarian cancer is named after his wife.
Patients
Precision medicine in action, with Cary Claiborne
Cary Claiborne, CEO of Adial Pharmaceuticals, discusses his company’s bet on a precision treatment for AUD.
R&D
Treating the chronic diseases GLP-1s miss, with Laurent Auda...
Prive Bio CEO Laurent Audaly spoke with pharmaphorum during the JP Morgan Healthcare conference, discussing GLP-1s in the cardiometabolic space.
R&D
The long-delayed promise of the microbiome, with Sam Possemi...
Sam Possemiers, CEO of MRM Health, believes that the microbiome space is finally coming into maturity.
Oncology
A cancer treatment modality that prioritises QoL, with Ben Z...
Immuneering's Ben Zeskind explains how, by focusing on quality of life as well as quantity, they've created a drug for pancreatic cancer.
Sales & Marketing
Digital
Market Access
Editor's Picks
Editor's Picks
